BAG3 Protein Is Over-Expressed in Endometrioid Endometrial Adenocarcinomas

Journal of Cellular Physiology

Volumn 232, Issue 2, 2017, Pages 309-311

  Esposito, Veronica ^a,b   Baldi, Carlo ^a   Zeppa, Pio ^a,b   Festa, Michelina ^a   Guerriero, Luana ^a   d’Avenia, Morena ^a   Chetta, Massimiliano ^a   Zullo, Fulvio ^b   De Laurenzi, Vincenzo ^a,c   Turco, Maria Caterina ^a,b   Rosati, Alessandra ^a,b   Guida, Maurizio ^a,b  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BAG3 PROTEIN; CHAPERONE; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BAG3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL MOTILITY; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERY ELDERLY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; METABOLISM; PATHOLOGY; STAINING; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, ENDOMETRIOID; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; STAINING AND LABELING;

EID: 84992560024     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25489     Document Type: Article

References (12)

1. Byers T, Sedjo RL. 2015. Body fatness as a cause of cancer: Epidemiologic clues to biologic mechanisms. Endocr Relat Cancer 22:R125–R134.
2. Dalamaga M, Diakopoulos KN, Mantzoros CS. 2012. The role of adiponectin in cancer: A review of current evidence. Endocr Rev 33:547–594.
3. Felzen V, Hiebel C, Koziollek-Drechsler I, Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C, Morawe T. 2015. Estrogen receptor ß regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function. Cell Death Dis 9:e1812.
4. Habata S, Iwasaki M, Sugio A, Suzuki M, Tamate M, Satohisa S, Tanaka R, Saito T. 2015. BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression. Oncol Rep 33:2613–2621.
5. Jardé T, Caldefie-Chézet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, Vasson MP. 2009. Involvement of adiponectin and leptin in breast cancer: Clinical and in vitro studies. Endocr Relat Cancer 16:1197–1210.
6. Murali R, Soslow RA, Weigelt B. 2014. Classification of endometrial carcinoma: More than two types. Lancet Oncol 15:e268–e278.
7. Ravo M, Cordella A, Rinaldi A, Bruno G, Alexandrova E, Saggese P, Nassa G, Giurato G, Tarallo R, Marchese G, Rizzo F, Stellato C, Biancardi R, Troisi J, Di Spiezio Sardo A, Zullo F, Weisz A, Guida M. 2015. Small non-coding RNA deregulation in endometrial carcinogenesis. Oncotarget 6:4677–4691.
8. Rosati A, Graziano V, De Laurenzi V, Pascale M, Turco MC. 2011. BAG3: A multifaceted protein that regulates major cell pathways. Cell Death Dis 7:e141.
9. Sugio A, Iwasaki M, Habata S, Mariya T, Suzuki M, Osogami H, Tamate M, Tanaka R, Saito T. 2014. BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer. Gynecol Oncol 134:615–623.
10. Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, Takayama S, Saito T. 2011. BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 303:65–71.
11. Yamauchi N, Takazawa Y, Maeda D, Hibiya T, Tanaka M, Iwabu M, Okada-Iwabu M, Yamauchi T, Kadowaki T, Fukayama M. 2012. Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues. Int J Gynecol Pathol 31:352–357.
12. Zheng Q, Wu H, Cao J. 2015. Circulating adiponectin and risk of endometrial cancer. PLoS ONE 10:e0129824.